Protein kinase A attenuates endothelial cell barrier dysfunction induced by microtubule disassembly

Anna A Birukova1, Feng Liu, Joe G N Garcia

  • 1Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.

Insights

Protein kinase A (PKA) activation protects endothelial barrier function by stabilizing microtubules and inhibiting actin-myosin contraction, offering a novel therapeutic target for endothelial barrier dysfunction.

Area of Science:

  • Cell Biology
  • Physiology

Background:

  • Endothelial barrier integrity is regulated by the actin cytoskeleton and microtubule (MT) network.
  • MT disruption leads to endothelial barrier dysfunction, characterized by increased MLC phosphorylation, actomyosin contraction, and cell retraction.
  • The protective mechanisms of protein kinase A (PKA) against endothelial barrier disruption are not fully understood.

Purpose of the Study:

  • To investigate the role of PKA in regulating endothelial permeability and cytoskeletal dynamics.
  • To elucidate the molecular mechanisms by which PKA protects the endothelial barrier from MT disassembly-induced dysfunction.

Main Methods:

  • Human pulmonary endothelial cells (EC) were treated with nocodazole to disrupt MTs.
  • Cells were stimulated with cholera toxin or forskolin to elevate cAMP levels and activate PKA.
  • Measurements included transendothelial electrical resistance (TEER), stress fiber formation, Rho activation, and MLC phosphorylation.

Main Results:

  • PKA activation by cholera toxin or forskolin attenuated nocodazole-induced decline in TEER.
  • PKA activation inhibited nocodazole-induced stress fiber formation, Rho activation, and MLC phosphorylation.
  • Forskolin pretreatment attenuated MT disassembly induced by nocodazole.

Conclusions:

  • PKA plays a critical role in stabilizing the MT cytoskeleton.
  • PKA activation provides a novel mechanism for regulating Rho-induced actin cytoskeletal remodeling and endothelial barrier dysfunction.
  • Targeting PKA may offer a therapeutic strategy for conditions involving endothelial barrier dysfunction.

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...